Top Markets
Coin of the day
Corix Bioscience, Inc. Corix Bioscience, Inc.

Corix Bioscience, Inc.

CXBS
Rank in Stocks #42267
Corix Bioscience, Inc. specializes in providing cannabidiol (CBD) oil, which is... Corix Bioscience, Inc. specializes in providing cannabidiol (CBD) oil, which is used for various medical applications. The company manages the full cycle of operations, from cultivating and harvesting industrial hemp plants to extracting the CBD oil. Formerly known as American Housing Income Trust, Inc., the organization rebranded as Corix Bioscience, Inc. in June 2017. Its corporate headquarters are situated in Phoenix, Arizona.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$2.73K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Corix Bioscience, Inc. (CXBS)

Category

P/E ratio for Corix Bioscience, Inc. (CXBS)
P/E ratio as of 2026 TTM: 0
According to Corix Bioscience, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Corix Bioscience, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.